Development of Rapidly Metabolized and Ultra-Short–Acting Ketamine Analogs

Show simple item record Harvey, M Sleigh, J Voss, L Jose, J Gamage, S Pruijn, F Liyanage, S Denny, W 2021-01-12T01:45:02Z 2021-01-12T01:45:02Z 2016-8
dc.identifier.issn 0039-6206
dc.description.abstract A major adverse effect of ketamine is its psychomimetic properties, which can cause prolonged psychic disturbances lasting 20 to 120 minutes after anesthesia. Ketamine analogs with rapid clearance might limit this pyschomimetic period to only a few minutes, while retaining the hypnotic characteristics of ketamine.
dc.language en
dc.publisher Ovid Technologies (Wolters Kluwer Health)
dc.relation.ispartofseries Survey of Anesthesiology
dc.rights Items in ResearchSpace are protected by copyright, with all rights reserved, unless otherwise indicated. Previously published items are made available in accordance with the copyright policy of the publisher.
dc.title Development of Rapidly Metabolized and Ultra-Short–Acting Ketamine Analogs
dc.type Journal Article
dc.identifier.doi 10.1097/SA.0000000000000243
pubs.issue 4
pubs.begin-page 170
pubs.volume 60 2020-12-02T08:51:53Z
dc.rights.holder Copyright: The author en
pubs.end-page 170
pubs.publication-status Published
dc.rights.accessrights en
pubs.subtype Editorial Comment
pubs.elements-id 612023

Files in this item

Find Full text

This item appears in the following Collection(s)

Show simple item record


Search ResearchSpace